ARCHIVES

Letter to the Editors: Burzynski Responds To FDA Release Of Annual Report Data

This article is from The Cancer Letter archive.

Vol. 24 No. 20 | May 22, 1998

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities (8-page issue).

May 23, 2003

Personal letters: mixed reviews of Donald Pinkel’s article on Childhood Lymphocytic Leukemia

May 6, 2021

The First BRCA1 Test Hits The Market; Are Oncologists, Patients Ready?

January 26, 1996

BCDDP Follow Up To Cost $1.6 Million annually For Five Years Okayed; Limited To 59,000 Women

November 3, 1978

In Brief: Thomas Jefferson Univ. Wins $5 Mil. P01; Former NCI Administrator Sentenced

November 6, 1992

Letter: Biostatistics Directors Invited To Share Concerns

June 7, 1996